LRE News

The third quarter wrapped up with four IPOs and eight pipeline additions. Oncology biotech Adlai Nortye (ANL) raised $58 million at an $849 million market cap. The company originally planned to raise $72 million in August but never priced; it removed and then set new terms earlier this month. Operating through subsidiaries in the US and China, Adlai...read more

Lead Real Estate, a luxury residential property developer in Japan, raised $8 million by offering 1.1 million ADSs at $7, the low end of the range of $7 to $9. Lead Real Estate is a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo and Kanagawa prefecture. It also operates hotels in Tokyo and leases apartment...read more

Updated Monday, 1/30. Three deals are currently scheduled for the week ahead, two of which qualify for inclusion in our IPO stats, though other small issuers may join the calendar last minute. Chronic disease biotech Structure Therapeutics (GPCR) leads the week's deals, planning to raise $125 million at a $511 million market...read more

Lead Real Estate, a luxury residential property developer in Japan, lowered the proposed deal size for its upcoming IPO on Friday. The Tokyo, Japan-based company now plans to raise $9 million by offering 1.1 million ADSs at a price range of $7 to $9. The company had most recently filed to offer 2 million ADSs at the same range. At the midpoint, Lead Real Estate will raise 43% less...read more